INS and type 2 diabetes mellitus: Consider initiating insulin therapy (with or without additional agents) in patients with type 2 diabetes who remain markedly symptomatic (weight loss, ketosis, polyuria, or polydipsia) and/or exhibit elevated blood glucose levels or HbA1c [85].